LAVA Therapeutics
LVTX
LVTX
22 hedge funds and large institutions have $6.15M invested in LAVA Therapeutics in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.29%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
8
Increased
5
Reduced
3
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$39.8K |
| 2 |
EGM
Engineers Gate Manager
New York
|
+$19.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$16.5K |
| 4 |
HF
HRT Financial
New York
|
+$16K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$12.5K |
Top Sellers
| 1 |
AWG
Alpha Wave Global
New York
|
-$145K |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
-$88.1K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$80K |
| 4 |
Two Sigma Investments
New York
|
-$51.3K |
| 5 |
Two Sigma Advisers
New York
|
-$44.7K |
